Agilent Asks Court to Review USPTO Decision Over Affymetrix IP Application | GenomeWeb
This update corrects the fact that Agilent has asked the court to review a USPTO decision, not that it has sued Affymetrix for patent infringement.
 
NEW YORK (GenomeWeb News) — Agilent Technologies last week asked a court to review a US Patent and Trademark Office decision that found that an Affymetrix patent application does not interfere with an existing Agilent patent.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.